Utilization of induced pluripotent stem cells to model the molecular network regulating congenital heart disease
Cardiovasc Res
.
2022 Feb 21;118(3):664-666.
doi: 10.1093/cvr/cvab373.
Authors
McKay M S Mullen
1
,
Joseph C Wu
1
Affiliation
1
Stanford Cardiovascular Institute, 240 Pasteur Drive, Room 3200, Palo Alto, CA, 94305, USA.
PMID:
34971365
PMCID:
PMC8859623
DOI:
10.1093/cvr/cvab373
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Heart Defects, Congenital* / genetics
Humans
Induced Pluripotent Stem Cells*
Myocytes, Cardiac / physiology
Grants and funding
R01 HL150693/HL/NHLBI NIH HHS/United States
R01 HL141371/HL/NHLBI NIH HHS/United States
R01 HL145676/HL/NHLBI NIH HHS/United States